260 related articles for article (PubMed ID: 24342995)
1. Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.
Fujita M; Cheng XW; Inden Y; Shimano M; Yoshida N; Inoue A; Yamamoto T; Takeshita K; Kyo S; Taguchi N; Shi GP; Kuzuya M; Okumura K; Murohara T
J Am Heart Assoc; 2013 Dec; 2(6):e000503. PubMed ID: 24342995
[TBL] [Abstract][Full Text] [Related]
2. Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.
Begg GA; Karim R; Oesterlein T; Graham LN; Hogarth AJ; Page SP; Pepper CB; Rhode K; Lip GYH; Holden AV; Plein S; Tayebjee MH
Europace; 2017 Dec; 19(12):1944-1950. PubMed ID: 28339804
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
[TBL] [Abstract][Full Text] [Related]
4. Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment.
Cheng XW; Murohara T; Kuzuya M; Izawa H; Sasaki T; Obata K; Nagata K; Nishizawa T; Kobayashi M; Yamada T; Kim W; Sato K; Shi GP; Okumura K; Yokota M
Am J Pathol; 2008 Aug; 173(2):358-69. PubMed ID: 18583318
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
6. Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice.
Mighiu AS; Recalde A; Ziberna K; Carnicer R; Tomek J; Bub G; Brewer AC; Verheule S; Shah AM; Simon JN; Casadei B
Cardiovasc Res; 2021 Sep; 117(11):2354-2364. PubMed ID: 33483749
[TBL] [Abstract][Full Text] [Related]
7. Circulating cathepsin K as a potential novel biomarker of coronary artery disease.
Cheng XW; Kikuchi R; Ishii H; Yoshikawa D; Hu L; Takahashi R; Shibata R; Ikeda N; Kuzuya M; Okumura K; Murohara T
Atherosclerosis; 2013 May; 228(1):211-6. PubMed ID: 23369704
[TBL] [Abstract][Full Text] [Related]
8. Mkk4 is a negative regulator of the transforming growth factor beta 1 signaling associated with atrial remodeling and arrhythmogenesis with age.
Davies L; Jin J; Shen W; Tsui H; Shi Y; Wang Y; Zhang Y; Hao G; Wu J; Chen S; Fraser JA; Dong N; Christoffels V; Ravens U; Huang CL; Zhang H; Cartwright EJ; Wang X; Lei M
J Am Heart Assoc; 2014 Apr; 3(2):e000340. PubMed ID: 24721794
[TBL] [Abstract][Full Text] [Related]
9. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V
Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596
[TBL] [Abstract][Full Text] [Related]
10. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
[TBL] [Abstract][Full Text] [Related]
11. H
Lu G; Xu C; Tang K; Zhang J; Li Q; Peng L; Wang Y; Huang Z; Gao X
Biochem Biophys Res Commun; 2017 Jan; 483(1):534-540. PubMed ID: 28011270
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation.
Pan CH; Lin JL; Lai LP; Chen CL; Stephen Huang SK; Lin CS
FEBS Lett; 2007 Feb; 581(3):526-34. PubMed ID: 17254576
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
Li D; Shinagawa K; Pang L; Leung TK; Cardin S; Wang Z; Nattel S
Circulation; 2001 Nov; 104(21):2608-14. PubMed ID: 11714658
[TBL] [Abstract][Full Text] [Related]
14. Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
Chilukoti RK; Mostertz J; Bukowska A; Aderkast C; Felix SB; Busch M; Völker U; Goette A; Wolke C; Homuth G; Lendeckel U
Int J Cardiol; 2013 Oct; 168(3):2100-8. PubMed ID: 23414741
[TBL] [Abstract][Full Text] [Related]
15. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
[TBL] [Abstract][Full Text] [Related]
16. Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline: The Multi-Ethnic Study of Atherosclerosis.
Duprez DA; Heckbert SR; Alonso A; Gross MD; Ix JH; Kizer JR; Tracy RP; Kronmal R; Jacobs DR
Circ Arrhythm Electrophysiol; 2018 Oct; 11(10):e006557. PubMed ID: 30354407
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling.
Walters TE; Kalman JM; Patel SK; Mearns M; Velkoska E; Burrell LM
Europace; 2017 Aug; 19(8):1280-1287. PubMed ID: 27738071
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes.
Lu G; Xu S; Peng L; Huang Z; Wang Y; Gao X
Biochem Biophys Res Commun; 2014 Nov; 454(3):410-6. PubMed ID: 25451261
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure.
Shimano M; Tsuji Y; Inden Y; Kitamura K; Uchikawa T; Harata S; Nattel S; Murohara T
Heart Rhythm; 2008 Mar; 5(3):451-9. PubMed ID: 18313605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
